Cytokine release syndrome (CRS) is an inflammatory response that can start quickly and affect the whole body. A variety of factors can cause it, including infections and certain drugs. CRS can occur after some types of immunotherapy treatments, such as chimeric antigen receptor (CAR) T-cell therapy.
When immune cells are affected by immunotherapy, the cells may quickly release a large amount of cytokines into the blood. Cytokines are small signaling proteins. They often act as messengers between cells. The rapid release of these proteins can cause an inflammatory response in the body.
CRS is graded from 1 (mild) to 4 (life-threatening) based on how severe the symptoms are. How mild or severe CRS is depends on factors such as the type of therapy that was used and the disease that is being treated.